| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 125, 2227-2229, Copyright © 1989 by Endocrine Society
ARTICLES |
M Murakami, H Suzuki, S Nakajima, H Nakamoto, Y Kageyama and T Saruta
Department of Internal Medicine, Keio University, School of Medicine, Tokyo, Japan.
This study examined the effects of calcitonin gene-related peptide (CGRP) on aldosterone secretion both in vivo and in vitro. Intravenous administration of CGRP (0.01 micrograms/kg) in 6 conscious dogs produced a significant decrease in plasma aldosterone concentration from 68 +/- 12 pg/ml to 28 +/- 11 pg/ml (p less than 0.05) despite a mild but significant elevation of plasma renin activity. In an in vitro study using isolated rabbit adrenal glomerulosa cells CGRP reduced the basal aldosterone secretion in a dose-related manner and furthermore 10(-9) M CGRP inhibited the aldosterone secretion stimulated by 10(-8) M angiotensin II. From these results it is suggested that CGRP has an inhibitory effect on aldosterone secretion.
This article has been cited by other articles:
![]() |
A. SPAT and L. HUNYADY Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways Physiol Rev, April 1, 2004; 84(2): 489 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Ulrich-Lai, C. A. Harding-Rose, A. Guo, W. R. Bowles, and W. C. Engeland ACTH inhibits the capsaicin-evoked release of CGRP from rat adrenal afferent nerves Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R137 - R142. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |